Omada Health President Shao Wei-Li sold 9,418 shares at $25.02 per share on Aug. 12, 2026. The transaction left the president with 307,372 shares, giving investors a disclosed view of executive ownership after the sale and the precise price attached to the transaction.
Key Highlights
- Shao Wei-Li’s reported transaction occurred on Aug. 12, 2026.
- Ownership after the sale stood at 307,372 Omada Health shares.
- The transaction was identified with code S.
Omada Health, Inc. (NASDAQ: OMDA) President Shao Wei-Li sold 9,418 shares at $25.02 per share on Aug. 12, 2026. The transaction left Shao Wei-Li with 307,372 shares of Omada Health.
Sale Involved 9,418 Shares The transaction was identified under code S.
Shao Wei-Li is Omada Health’s president, and the reported sale covered shares priced at $25.02 each. The post-transaction ownership figure was 307,372 shares. Shao Wei-Li’s transaction involved 9,418 shares. The reported price was $25.02 per share, and the transaction date was Aug. 12, 2026.
FAQs
Q: What did Shao Wei-Li sell in Omada Health?
A: Shao Wei-Li sold 9,418 Omada Health shares at $25.02 per share on Aug. 12, 2026, in a transaction identified under code S.
Q: How many Omada Health shares does Shao Wei-Li own after the sale?
A: Omada Health President Shao Wei-Li owned 307,372 shares after the reported transaction, according to the disclosed post-sale ownership figure. The filing reports this figure as her ownership following the transaction.
Q: What transaction details does the filing report?
A: The filing reports a sale of 9,418 shares at $25.02 per share on Aug. 12, 2026, identified under transaction code S.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.